ESH Video

#ESHCMLMPN2025 THE DEADLINE TO SUBMIT YOUR ABSTRACT IS APPROACHING...

November 25, 2024

4th How to Diagnose and Treat:

CML/MPN

 

March 07-09, 2025
Vienna, Austria
#ESHCMLMPN2025

 

 

 


 

THE DEADLINE FOR THE SUBMISSION OF ABSTRACTS
AND CLINICAL CASES IS ON DECEMBER 15th

DON'T MISS THE OPPORTUNITY:

 

 


 

THE CONFERENCE'S MAIN SCIENTIFIC TOPICS
• MPN - ABC of standard care
• MPN - Challenging clinical scenarios
• MPN Management
• CML - Risk assessment
• CML - Challenging clinical scenarios
• CML - Treatment optimization
• CML & MPN - Long term complications
• CML & MPN - What is on the horizon?

 

 


 

ABOUT THE CONFERENCE:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.

Building on the success of our 3 previous meetings, the programme for this clinically orientated meeting will allow the attendee to be immersed in the most up-to-date information for practical management of both common and rarer scenarios across the spectrum of CML and MPN and related conditions.

Our faculty is a host of international experts who will focus their interactions around difficult clinical scenarios and there will also be a variety of case-based discussions and debates.



This meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior scientists and clinicians (MD, PhD)
• PhD candidates and clinical residents still in-training

 

 

 

 


 

THE PROGRAMME WILL INCLUDE:
Case-based lectures - Interactive Case Presentations - Roundtables
Panel Discussions - Debates - Meet the Expert Sessions
Poster Walks - Voting technology

 

CLICK HERE TO ACCESS THE PRELIMINARY PROGRAMME

MORE INFORMATION

 


 

With the support of*:



Level 2 Conference Partners
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.